Generative AI in glioma: Ensuring diversity in training image phenotypes to improve diagnostic performance for IDH mutation prediction.

Journal: Neuro-oncology
Published Date:

Abstract

BACKGROUND: This study evaluated whether generative artificial intelligence (AI)-based augmentation (GAA) can provide diverse and realistic imaging phenotypes and improve deep learning-based classification of isocitrate dehydrogenase (IDH) type in glioma compared with neuroradiologists.

Authors

  • Hye Hyeon Moon
    Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Jiheon Jeong
    Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Ji Eun Park
    Department of Anatomy and Cell Biology, College of Medicine, Dong-A University, Busan 602-714, Korea.
  • Namkug Kim
    Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Changyong Choi
    Department of Bioengineering, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, 88 Olympic-Ro 43-Gil Songpa-Gu, Seoul, 05505, South Korea.
  • Young-Hoon Kim
    Department of Orthopedic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Sang Woo Song
    Department of Neurosurgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Chang-Ki Hong
    Department of Neurosurgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Jeong Hoon Kim
    Department of Neurosurgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Ho Sung Kim
    Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.